Micellar Nanoformulation of Berberine to Mitigate Doxorubicin-induced Cardiotoxicity: A Cell-line Study
Background: Doxorubicin-induced cardiotoxicity (DIC) is a major complication of cancer chemotherapy. Thus, developing effective myocardial protection strategies during doxorubicin (Dox) therapy is a medical necessity.Objectives: To evaluate and compare the cardioprotective effectiveness of free berb...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University of Anbar
2023-12-01
|
| Series: | Al-Anbar Medical Journal |
| Subjects: | |
| Online Access: | https://amj.uoanbar.edu.iq/article_181120_bc2ef32fefa361cd6a3125c931029fc3.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850064425714712576 |
|---|---|
| author | Noora Alyasari Anwar Almzaiel |
| author_facet | Noora Alyasari Anwar Almzaiel |
| author_sort | Noora Alyasari |
| collection | DOAJ |
| description | Background: Doxorubicin-induced cardiotoxicity (DIC) is a major complication of cancer chemotherapy. Thus, developing effective myocardial protection strategies during doxorubicin (Dox) therapy is a medical necessity.Objectives: To evaluate and compare the cardioprotective effectiveness of free berberine (Ber) and berberine loaded in micelles (mBer) against DIC.Materials and Methods: The study, which was conducted in 2023, employed the H9c2 cell line, derived from embryonic cardiomyocytes, as a model. The study included a control group and six experimental groups: the Ber-treated group, the mBer-treated group, the Dox-treated group, the Ber-Dox combination-treated group, and the mBer-Dox combination-treated group, as well as the void micelles-treated group. The study evaluated the alterations in several cardiotoxicity markers with triplicate measurements: [lactate dehydrogenase (LDH), creatine kinase myocardial band (CK-MB), and cardiac troponin I (cTn-1)], lipid peroxidation indicator (malondialdehyde (MDA), oxidative stress markers [Reduced glutathione (GSH), catalase (CAT), and superoxide dismutase (SOD), inflammatory cytokines (interleukin-1β (IL-1β) and interleukin-6 (IL-6)], and the activity of the apoptosis proteins caspases 3/7. Results: The DOX group demonstrated significant increases in cardiotoxicity enzyme indices, lipid peroxidation, generation of free radicals, inflammatory cytokines, and caspase 3/7 activity relative to the control group. When Ber, or mBer, was co-delivered with Dox, the levels of LDH, CK-MB, cTn-1, and MDA significantly decreased. Whereas the activities of SOD and CAT were significantly improved when Ber, or mBer, was co-delivered with Dox. They reduced the elevation in both IL- β and IL-6 levels as well as the activities of caspases 3 and 7 induced by Dox. Importantly, the utilization of the micellar formulation of Ber in conjunction with Dox significantly enhanced the cardioprotective efficacy of Ber against DIC in H9c2 cells. Conclusion: Our results suggest that mBer offers a novel Ber delivery approach and prospective therapeutic strategy for the treatment of DIC. |
| format | Article |
| id | doaj-art-1f73f1b157ce40a7af67cd85434cdd4d |
| institution | DOAJ |
| issn | 2706-6207 2664-3154 |
| language | English |
| publishDate | 2023-12-01 |
| publisher | University of Anbar |
| record_format | Article |
| series | Al-Anbar Medical Journal |
| spelling | doaj-art-1f73f1b157ce40a7af67cd85434cdd4d2025-08-20T02:49:19ZengUniversity of AnbarAl-Anbar Medical Journal2706-62072664-31542023-12-0119214815410.33091/amj.2023.141684.1254181120Micellar Nanoformulation of Berberine to Mitigate Doxorubicin-induced Cardiotoxicity: A Cell-line StudyNoora Alyasari0Anwar Almzaiel1Ph.D. candidate. University of Al-QadisiyahDepartment of Biochemistry, College of Medicine, University of Al-Qadisiyah, Diwaniyah, IraqBackground: Doxorubicin-induced cardiotoxicity (DIC) is a major complication of cancer chemotherapy. Thus, developing effective myocardial protection strategies during doxorubicin (Dox) therapy is a medical necessity.Objectives: To evaluate and compare the cardioprotective effectiveness of free berberine (Ber) and berberine loaded in micelles (mBer) against DIC.Materials and Methods: The study, which was conducted in 2023, employed the H9c2 cell line, derived from embryonic cardiomyocytes, as a model. The study included a control group and six experimental groups: the Ber-treated group, the mBer-treated group, the Dox-treated group, the Ber-Dox combination-treated group, and the mBer-Dox combination-treated group, as well as the void micelles-treated group. The study evaluated the alterations in several cardiotoxicity markers with triplicate measurements: [lactate dehydrogenase (LDH), creatine kinase myocardial band (CK-MB), and cardiac troponin I (cTn-1)], lipid peroxidation indicator (malondialdehyde (MDA), oxidative stress markers [Reduced glutathione (GSH), catalase (CAT), and superoxide dismutase (SOD), inflammatory cytokines (interleukin-1β (IL-1β) and interleukin-6 (IL-6)], and the activity of the apoptosis proteins caspases 3/7. Results: The DOX group demonstrated significant increases in cardiotoxicity enzyme indices, lipid peroxidation, generation of free radicals, inflammatory cytokines, and caspase 3/7 activity relative to the control group. When Ber, or mBer, was co-delivered with Dox, the levels of LDH, CK-MB, cTn-1, and MDA significantly decreased. Whereas the activities of SOD and CAT were significantly improved when Ber, or mBer, was co-delivered with Dox. They reduced the elevation in both IL- β and IL-6 levels as well as the activities of caspases 3 and 7 induced by Dox. Importantly, the utilization of the micellar formulation of Ber in conjunction with Dox significantly enhanced the cardioprotective efficacy of Ber against DIC in H9c2 cells. Conclusion: Our results suggest that mBer offers a novel Ber delivery approach and prospective therapeutic strategy for the treatment of DIC.https://amj.uoanbar.edu.iq/article_181120_bc2ef32fefa361cd6a3125c931029fc3.pdfberberinedoxorubicincardiotoxicitypolymeric nanomicelleh9c2 |
| spellingShingle | Noora Alyasari Anwar Almzaiel Micellar Nanoformulation of Berberine to Mitigate Doxorubicin-induced Cardiotoxicity: A Cell-line Study Al-Anbar Medical Journal berberine doxorubicin cardiotoxicity polymeric nanomicelle h9c2 |
| title | Micellar Nanoformulation of Berberine to Mitigate Doxorubicin-induced Cardiotoxicity: A Cell-line Study |
| title_full | Micellar Nanoformulation of Berberine to Mitigate Doxorubicin-induced Cardiotoxicity: A Cell-line Study |
| title_fullStr | Micellar Nanoformulation of Berberine to Mitigate Doxorubicin-induced Cardiotoxicity: A Cell-line Study |
| title_full_unstemmed | Micellar Nanoformulation of Berberine to Mitigate Doxorubicin-induced Cardiotoxicity: A Cell-line Study |
| title_short | Micellar Nanoformulation of Berberine to Mitigate Doxorubicin-induced Cardiotoxicity: A Cell-line Study |
| title_sort | micellar nanoformulation of berberine to mitigate doxorubicin induced cardiotoxicity a cell line study |
| topic | berberine doxorubicin cardiotoxicity polymeric nanomicelle h9c2 |
| url | https://amj.uoanbar.edu.iq/article_181120_bc2ef32fefa361cd6a3125c931029fc3.pdf |
| work_keys_str_mv | AT nooraalyasari micellarnanoformulationofberberinetomitigatedoxorubicininducedcardiotoxicityacelllinestudy AT anwaralmzaiel micellarnanoformulationofberberinetomitigatedoxorubicininducedcardiotoxicityacelllinestudy |